Comparison of Intermittent Preventive Treatment with Chemoprophylaxis for the Prevention of Malaria during Pregnancy in Mali
Author(s) -
Kassoum Kayentao,
Mamoudou Kodio,
Robert D. Newman,
Hamma Maiga,
Didier Doumtabé,
Aissata Ongoïba,
Drissa Coulibaly,
Abdoul Salam Keita,
Bouboucar Maiga,
Mary Mungai,
Monica E. Parise,
Ogobara K. Doumbo
Publication year - 2004
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/426400
Subject(s) - chemoprophylaxis , sulfadoxine , malaria , medicine , chloroquine , pregnancy , pyrimethamine , malaria prophylaxis , malaria prevention , obstetrics , anemia , adverse effect , pediatrics , low birth weight , surgery , immunology , environmental health , population , health services , biology , genetics
Malaria during pregnancy contributes to maternal anemia and low birth weight. In East Africa, several studies have demonstrated that intermittent preventive treatment (IPT) with sulfadoxine-pyrimethamine (SP) is more efficacious than weekly chloroquine (CQ) chemoprophylaxis in preventing these adverse consequences. To our knowledge, there are no published trials evaluating IPT in West Africa.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom